Scott Z. Fields

Topotecan Versus Cyclophosphamide, Doxorubicin, and Vincristine for the Treatment of Recurrent Small-Cell Lung Cancer

Joachim von Pawel, Joan H. Schiller, Frances A. Shepherd et al. · Journal of Clinical Oncology · 1999 · 943 citations

Topotecan for the treatment of advanced epithelial ovarian cancer: an open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel.

M. A. Bookman, Henric Malmström, Giorgio Bolis et al. · Journal of Clinical Oncology · 1998 · 334 citations

Epratuzumab, a Humanized Anti-CD22 Antibody, in Aggressive Non-Hodgkin’s Lymphoma

John P. Leonard, Morton Coleman, Jamie Ketas et al. · Clinical Cancer Research · 2004 · 226 citations

Subcellular distribution of daunorubicin in P-glycoprotein-positive and -negative drug-resistant cell lines using laser-assisted confocal microscopy.

James E. Gervasoni, Scott Z. Fields, Sindu Krishna et al. · PubMed · 1991 · 158 citations

Cellular Pharmacology, Pharmacotherapy, Cell Biophysics +16

A randomised trial of oral versus intravenous topotecan in patients with relapsed epithelial ovarian cancer

Martin Gore, Amit M. Oza, Gordon Rustin et al. · European Journal of Cancer · 2002 · 110 citations

Medicine, Randomised Trial, Cancer Management +7